{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:00:42Z","timestamp":1791453642672,"version":"4.3.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T00:00:00Z","timestamp":1691884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009335","name":"Northern Savo Hospital District","doi-asserted-by":"publisher","award":["13\/2012"],"award-info":[{"award-number":["13\/2012"]}],"id":[{"id":"10.13039\/501100009335","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.clml.2023.08.009","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T03:36:31Z","timestamp":1692329791000},"page":"e428-e435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-2582","authenticated-orcid":false,"given":"Anu","family":"Partanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3693-2956","authenticated-orcid":false,"given":"Antti","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8884-1896","authenticated-orcid":false,"given":"Jaakko","family":"Valtola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"Py\u00f6r\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9969-0053","authenticated-orcid":false,"given":"Outi","family":"Kuittinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Kuitunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaija","family":"Vasala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karri","family":"Penttil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taru","family":"Kuittinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pentti","family":"M\u00e4ntymaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Pelkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa","family":"Jantunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5070-6018","authenticated-orcid":false,"given":"Ville","family":"Varmavuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clml.2023.08.009_bib0001","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41409-022-01604-x","article-title":"European Society for Blood and Marrow Transplantation (EBMT). Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey","volume":"57","author":"Passweg","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.clml.2023.08.009_bib0002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.transci.2012.05.012","article-title":"Impact of age and diagnosis on viability during centrifugation and cryopreservation of peripheral blood stem cell products","volume":"47","author":"Civriz Bozdag","year":"2012","journal-title":"Transfus Apher Sci"},{"issue":"6","key":"10.1016\/j.clml.2023.08.009_bib0003","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jca.21550","article-title":"Pegylated granulocyte-colony stimulating factor versus non-pegylated granulocyte-colony stimulating factor for peripheral blood stem cell mobilization: a systematic review and meta-analysis","volume":"32","author":"Kuan","year":"2017","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.clml.2023.08.009_bib0004","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41409-019-0693-z","article-title":"Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor","volume":"55","author":"Sureda","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.clml.2023.08.009_bib0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jcyt.2019.04.004","article-title":"Cryopreservation and thawing of hematopoietic stem cell CD34-induced apoptosis through caspase pathway activation: Key role of granulocytes","volume":"21","author":"Desoutter","year":"2019","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.clml.2023.08.009_bib0006","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bmt.2013.152","article-title":"Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion","volume":"49","author":"Shu","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.clml.2023.08.009_bib0007","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1537-2995.2004.03336.x","article-title":"Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide","volume":"44","author":"Abrahamsen","year":"2004","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.clml.2023.08.009_bib0008","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1537-2995.2008.01648.x","article-title":"Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation","volume":"48","author":"Akk\u00f6k","year":"2008","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.clml.2023.08.009_bib0009","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jcyt.2017.12.005","volume":"20","author":"Holbro","year":"2018","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.clml.2023.08.009_bib0010","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.toxlet.2005.02.003","article-title":"Behavioural effects of dimethyl sulfoxide (DMSO): changes in sleep architecture in rats","volume":"157","author":"Cavas","year":"2005","journal-title":"Toxicol Lett"},{"issue":"1","key":"10.1016\/j.clml.2023.08.009_bib0011","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/vox.12012","article-title":"Long-term cryopreservation in 5% DMSO maintains unchanged CD34(+) cells viability and allows satisfactory hematological engraftment after peripheral blood stem cell transplantation","volume":"105","author":"Abbruzzese","year":"2013","journal-title":"Vox Sang"},{"issue":"5","key":"10.1016\/j.clml.2023.08.009_bib0012","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/bjh.14378","article-title":"Optimisation and quality control of cell processing for autologous stem cell transplantation","volume":"175","author":"Watts","year":"2016","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.clml.2023.08.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102753","article-title":"Manipulation and cryopreservation of autologous peripheral blood stem cell products in Italy: A survey by GITMO, SIDEM and GIIMA societies","volume":"59","author":"Lanza","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.clml.2023.08.009_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103298","article-title":"Effects of cell concentration, time of fresh storage, and cryopreservation on peripheral blood stem cells: PBSC fresh storage and cryopreservation","volume":"61","author":"Ara\u00fajo","year":"2022","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.clml.2023.08.009_bib0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/14653249.2011.610302","article-title":"Increased apoptosis in cryopreserved autologous hematopoietic progenitor cells collected by apheresis and delayed neutrophil recovery after transplantation: a nested case-control study","volume":"14","author":"Wu","year":"2012","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.clml.2023.08.009_bib0016","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1423-0410.2007.01009.x","article-title":"Post thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation","volume":"94","author":"Lee","year":"2008","journal-title":"Vox Sang"},{"issue":"5","key":"10.1016\/j.clml.2023.08.009_bib0017","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1083-8791(00)70021-8","article-title":"Favourable treatment outcome in non-Hodgkin's lymphoma patients with \"poor\" mobilization of peripheral blood progenitor cells","volume":"6","author":"Stockerl-Goldstein","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.clml.2023.08.009_bib0018","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1705763","article-title":"Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies","volume":"40","author":"Bolwell","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.clml.2023.08.009_bib0019","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14653240310000083","article-title":"Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study","volume":"5","author":"Gratama","year":"2003","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1016\/j.clml.2023.08.009_bib0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bmt.1703575","article-title":"Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation","volume":"29","author":"Allan","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.clml.2023.08.009_bib0021","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1080\/10428194.2020.1762879","article-title":"Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study","volume":"61","author":"Turunen","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.clml.2023.08.009_bib0022","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/trf.16198","article-title":"Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study","volume":"61","author":"Partanen","year":"2021","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.clml.2023.08.009_bib0023","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1111\/j.1537-2995.2010.02746.x","article-title":"Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft","volume":"50","author":"Tr\u00e9b\u00e9den-Negre","year":"2010","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.clml.2023.08.009_bib0024","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bmt.1705501","article-title":"Overnight storage of autologous stem cell apheresis products before cryopreservation does not adversely impact early or long-term engraftment following transplantation","volume":"38","author":"Parkins","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2023.08.009_bib0025","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.927084","article-title":"Outcomes of non-cryopreserved versus cryopreserved peripheral blood stem cells for autologous stem cell transplantation in multiple myeloma","volume":"25","author":"Piriyakhuntorn","year":"2020","journal-title":"Ann Transplant"},{"key":"10.1016\/j.clml.2023.08.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211036004","article-title":"Long-term cryopreservation does not affect quality of peripheral blood stem cell grafts: a comparative study of native, short-term and long-term cryopreserved haematopoietic stem cells","volume":"30","author":"Lysak","year":"2021","journal-title":"Cell Transplant"},{"issue":"3","key":"10.1016\/j.clml.2023.08.009_bib0027","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3324\/haematol.12081","article-title":"Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor","volume":"93","author":"Bruns","year":"2008","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.clml.2023.08.009_bib0028","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","article-title":"An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy","volume":"86","author":"Weaver","year":"1995","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clml.2023.08.009_bib0029","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbmt.2010.11.021","article-title":"Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma","volume":"17","author":"Stiff","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.clml.2023.08.009_bib0030","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/j.1537-2995.2009.02202.x","article-title":"Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma","volume":"49","author":"Yoon","year":"2009","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.clml.2023.08.009_bib0031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jca.22022","article-title":"Impact of the number of cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: Experience from the GOA study","volume":"38","author":"Partanen","year":"2023","journal-title":"J Clin Apher"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023002562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023002562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:44:03Z","timestamp":1761871443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265023002562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2152265023002562"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.08.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}